{"id":"W2022301990","doi":"10.1016/j.cgh.2010.04.021","title":"Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab","year":2010,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; National Cancer Institute","keywords":"Certolizumab pegol; Medicine; Infliximab; Internal medicine; Maintenance therapy; Crohn's disease; Gastroenterology; Surgery; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009910692,0.0002345601,0.0003491955,0.00008649822,0.0000743093,0.00001831413,0.00016365,0.0002845168,0.00004223988],"category_scores_gemma":[0.0001768171,0.0002115106,0.00005048723,0.00003637911,0.0003275193,0.00001015425,0.0003186305,0.0004164992,0.00001401245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006142468,"about_ca_system_score_gemma":0.000107081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005561912,"about_ca_topic_score_gemma":0.002343423,"domain_scores_codex":[0.998174,0.0001980077,0.0003982765,0.000703524,0.00006535053,0.0004608561],"domain_scores_gemma":[0.99877,0.00002928277,0.00007375372,0.0003791669,0.00009043815,0.0006573892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02079912,0.000195061,0.9768873,0.00002079264,0.00004493819,0.0005387975,0.00002837654,0.000007050178,0.00008120921,0.0000664867,0.0007774177,0.0005534016],"study_design_scores_gemma":[0.004725105,0.001102939,0.9922782,0.000008151589,0.00003104903,0.00007509888,0.00001026264,0.00004430002,0.000007592542,0.00008304745,0.00146846,0.000165752],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968973,0.00001135457,0.00009354825,0.002242922,0.0001754599,0.0004585762,0.00006831393,0.00001264642,0.00003983791],"genre_scores_gemma":[0.9939932,0.000007754614,0.0007916461,0.004916544,0.00008935267,0.00007045834,0.00007018216,0.0000237841,0.00003708158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01607402,"threshold_uncertainty_score":0.8625151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005757835295310622,"score_gpt":0.2482573645422792,"score_spread":0.2424995292469686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}